MAGI2 and colorectal carcinoma: In same direction, in 2020, Xi Yang [57] and colleagues demonstrated that the MAGI2-AS3 rs7783388 polymorphism can increase the risk of CRC by affecting the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter [57].